Spire announces 7.4% fall in EBITDA as slowdown in NHS demand continues

Spire Healthcare has announced a 7.4% fall in EBITDA to £150m for 2017 as softening NHS demand impacted the business in the second half. The company hit revised guidance for the full year – just – after reporting a 1% rise in revenue to £931.7m. EBITDA was in line with the £149m to £151m guide…

You must be a HM Subscriber to view this content.

Subscribe Now »